Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Jinling Hospital, China
Centre of Postgraduate Medical Education
National Health Research Institutes, Taiwan
University Health Network, Toronto
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University Medical Center Groningen
Medical University of Graz
Instituto do Cancer do Estado de São Paulo
Imperial College London
University Hospital, Ghent
University of Florence
Medipol University
Hospices Civils de Lyon
Samsun Liv Hospital
University Hospital Schleswig-Holstein
Fundacio Puigvert
Université de Sousse
Samsun Liv Hospital
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Oslo University Hospital